Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06643715Not ApplicableRecruiting

Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"

Role: collaborator

NCT06459167Not ApplicableNot Yet Recruiting

Position Intervention to Reduce Hypoxemia in Sedation Patients

Role: collaborator

NCT05994872Not ApplicableNot Yet Recruiting

Reverse Drilling Technique in Improving Outcomes After Arthroscopic Anterior Cruciate Ligament Reconstruction

Role: collaborator

NCT05183958Phase 2Unknown

A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer

Role: collaborator

All 4 trials loaded